BAFF et al.: novel members of the TNF ligand and receptor families as therapeutic targets

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.9, 2002-09, pp. : 1351-1365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of TNF-related apoptosis-inducing ligand receptor antibodies

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. : 1081-1086

Informa Healthcare

Access to resources Recommend Favorite

Novel natural vanilloid receptor agonists: new therapeutic targets for drug development

By Sterner O. Szallasi A.

Trends in Pharmacological Sciences, Vol. 20, Iss. 11, 1999-11 ,pp. : 459-465

Elsevier

Access to resources Recommend Favorite

Novel therapeutic targets in chordoma

By Bydon Mohamad Papadimitriou Kyriakos Witham Timothy Wolinsky Jean-Paul Bydon Ali Sciubba Daniel Gokaslan Ziya

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1139-1143

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic targets in osteoporosis

By Tobias JH Flanagan AM Scutt AM

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 41-56

Informa Healthcare

Access to resources Recommend Favorite

Activins, Myostatin and Related TGF-&bgr; Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune Disorders

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 157-166

Bentham Science Publishers

Access to resources Recommend Favorite